MARC details
| 000 -LEADER |
|---|
| fixed length control field |
06351cam a22004214a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
14902847 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
KENaKMTC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20151007182323.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
070622s2008 pauaf b 001 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2007026228 |
| 016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER |
|---|
| Record control number |
101310072 |
| Source |
DNLM |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780781768795 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0781768799 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9788189960308 |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)ocn145942325 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DNLM/DLC |
| Transcribing agency |
DLC |
| Modifying agency |
NLM |
| -- |
BAKER |
| -- |
MUQ |
| -- |
YDXCP |
| -- |
COU |
| -- |
C#P |
| -- |
BWX |
| -- |
BTCTA |
| -- |
DLC |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
pcc |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RS403.F69 2008 |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
616.07/56 |
| Edition number |
22 |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Foye's principles of medicinal chemistry / |
| Statement of responsibility, etc |
edited by Thomas L. Lemke, David A. Williams ; assistant editors, Victoria F. Roche, S. William Zito ... [et al.]. |
| 246 30 - VARYING FORM OF TITLE |
|---|
| Title proper/short title |
Principles of medicinal chemistry |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
6th ed. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
New Delhi : |
| Name of publisher, distributor, etc |
Wolters Kluwer/Lippincott Williams & Wilkins, |
| Date of publication, distribution, etc |
c2008. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xiv, 1377 p., 8 p. of plates ; |
| Other physical details |
ill. (some col.) |
| Dimensions |
29 cm. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Historical perspective of medicinal chemistry / John L. Neumeyer --<br/>pt. I: Principles of drug discovery --<br/>Chapter 1: Drug discovery from natural products / A. Douglas Kinghorn --<br/>Chapter 2: Drug design and relationship of functional groups to pharmacologic activity / James J. Knittel and Robin M. Zavod --<br/>Chapter 3: Molecular modeling and in Silico drug design / Xiang-Qun (Sean) Xie --<br/>Chapter 4: Receptors and drug action / Timothy A. Maher and David A. Johnson --<br/>Chapter 5: Drug discovery through enzyme inhibition / Stephen Kerr --<br/>Chapter 6: Pharmaceutical biotechnology-from nucleic acids to personalized medicine / Ronald E. Reid and Robert D. Sindelar --<br/>Chapter 7: Peptide and protein drugs / Michael Mokotoff --<br/>Chapter 8: Antisense therapeutic agents / Marilyn Speedie --<br/>Chapter 9: Physicochemical and biopharmaceutical properties of drug substances and pharmacokinetics / Sunil S. Jambhekar --<br/>Chapter 10: Drug metabolism / David A. Williams --<br/>Chapter 11: U.S. drug regulation: an overview / Douglas --<br/>Part II: Drug receptors affecting neurotransmission and enzymes as catalytic receptors : overview of Drug Receptors: A Perspective / David J. Triggle --<br/>Chapter 12: Drugs affecting cholinergic neurotransmission / E. Kim Fifer --<br/>Chapter 13: Adrenergic receptors and drugs affecting adrenergic neurotransmission / Robert K. Griffith --<br/>Chapter 14: Serotonin receptors and drugs affecting serotonergic neurotransmission / Richard A. Glennon and Malgorzata Dukat-Glennon --<br/>Chapter 15: Amino acid neurotransmitters in the central nervous system / Timothy J. Maher --<br/>Chapter 16: Inhibitors of nerve conduction: local anesthetics / Matthias C. Lu --<br/>Chapter 17: Phosphodiesterase inhibitors / Kevin Dalby --<br/>Part III: Pharmacodynamic Agents --<br/>Section 1: Drugs affecting central nervous system --<br/>Chapter 18: General anesthetics / Timothy J. Maher --<br/>Chapter 19: Sedative-hypnotics / William Soine --<br/>Chapter 20: Antiseizure agents / Barbara Leduc --<br/>Chapter 21: Antidepressants / David A. Williams --<br/>Chapter 22: Psychotherapeutic drugs: antipsychotic and anxiolytic agents / Raymond G. Booth --<br/>Chapter 23: Hallucinogens, stimulants and related drugs of abuse / Richard A. Glennon --<br/>Chapter 24: Opioid analgesics / David S. Fries --<br/>Chapter 25: Drugs used to treat neuromuscular disorders: antiparkinsonian and spasmolytic agents / Raymond G. Booth. Section 2: Drugs affecting the cardiovascular system --<br/>Chapter 26: Cardiac agents: Cardiac glycosides, antianginal, and antiarrhythmic drugs / Ahmed S. Mehanna --<br/>Chapter 27: Diuretics / Gary O. Rankin --<br/>Chapter 28: Angiotensin converting enzyme inhibitors, antagonists and calcium blockers / Marc Harrold --<br/>Chapter 29: Central and peripheral sympatholytics and vasodilators / David A. Williams --<br/>Chapter 30: Antihyperlipoproteinemics and inhibitors of cholesterol biosynthesis / Marc Harrold --<br/>Chapter 31: Antithrombotics, thrombolytics, coagulants, and plasma extenders / Matthias C. Lu and Thomas L. Lemke --<br/>Section 3: Drugs affecting the hormonal systems --<br/>Chapter 32: Insulin and drugs used for the treatment of diabetes / Robin M. Zavod, John L. Krstenansky, and Bruce L. Currie --<br/>Chapter 33: Adrenocorticoids / Duane D. Miller, Robert W. Brueggemeier and James T. Dalton --<br/>Chapter 34: Thyroid function and thyroid drugs / Ali R. Banijamali --<br/>Chapter 35: Calcium homeostasis / Robin M. Zavod --<br/>Section 4: Drugs affecting the immune systems --<br/>Chapter 36: Nonsteroidal anti-inflammatory drugs / Wendel L. Nelson --<br/>Chapter 37: Antihistamines and related antiallergic and antiulcer agents --<br/>Section 5: Chemotherapeutic agents --<br/>Chapter 38: Antibiotics and antimicrobial agents / Lester A. Mitscher, Thomas L. Lemke, and Elmer J. Gentry --<br/>Chapter 39: Antiparasitic agents: Thomas L. Lemke --<br/>Chapter 40: Antifungal agents / Robert K. Griffith --<br/>Chapter 41: Antimycobacterial agents /Thomas L. Lemke --<br/>Chapter 42: Cancer and chemotherapy / Victoria F. Roche --<br/>Chapter 43: Antiviral agents and protease inhibitors / Patrick M. Woster --<br/>Part IV: Disease state management --<br/>Chapter 44: Asthma and chronic obstructive pulmonary disease S. William Zito --<br/>Chapter 45: Men' Health / Duane D. Miller, Robert W. Brueggermeier, and James T. Dalton --<br/>Chapter 46: Women's Health / Robin M. Zavod.<br/> |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
This comprehensive text has been fully revised and updated to meet the changing curricula of medicinal chemistry courses. Emphasis is on patient-focused pharmaceutical care and on the pharmacist as a therapeutic consultant, rather than a chemist. A new disease state management section explains appropriate therapeutic options for asthma, chronic obstructive pulmonary disease, and men's and women's health problems. Read more... |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmaceutical chemistry. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Chemistry, Pharmaceutical. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Foye, William O. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Lemke, Thomas L. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Williams, David A., |
| Dates associated with a name |
1938- |
| 856 42 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
Publisher description |
| Uniform Resource Identifier |
<a href="http://www.loc.gov/catdir/enhancements/fy0912/2007026228-d.html">http://www.loc.gov/catdir/enhancements/fy0912/2007026228-d.html</a> |
| 856 41 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
Table of contents only |
| Uniform Resource Identifier |
<a href="http://www.loc.gov/catdir/enhancements/fy0912/2007026228-t.html">http://www.loc.gov/catdir/enhancements/fy0912/2007026228-t.html</a> |
| 906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) |
|---|
| a |
7 |
| b |
cbc |
| c |
orignew |
| d |
1 |
| e |
ecip |
| f |
20 |
| g |
y-gencatlg |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Library of Congress Classification |
| Koha item type |
Books |
| Intials |
RJ |
